Skip to main content
. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3

Comparison 13. Adequate concealment spasmolytic agents: global assessment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 comparing nrs of successfully treated IBS patients with spasmolytic agents 3 219 Risk Ratio (M‐H, Fixed, 95% CI) 1.35 [0.85, 2.12]